RA'ANANA, Israel, Sept. 6, 2010 (GLOBE NEWSWIRE) -- Retalix® Ltd. (Nasdaq:RTLX) announced today the appointment of Avi Naor, a member of Retalix's board of directors, to chairman of the board. The appointment follows Eli Gelman's request to step down from the chairman of the board position to carry out his responsibilities as the new CEO and president of Amdocs. Gelman will continue to serve as a member of the board of directors of Retalix. Naor and Gelman are members of the Alpha Group and joined Retalix's board of directors in 2009, when the Alpha Group acquired a 20% share in the company and entered into a shareholder agreement with the FIMI Fund. Naor's appointment will take effect in the first quarter of 2011.
Avi Naor Appointed As Chairman Of Retalix
Check Out Our Best Services for Investors
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.